Rp1,083.40
+ Rp28.50 (2.70%)
End-of-day quote: 12/09/2021
BSE:539871

Thyrocare Technologies (539871)

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India.

If you are interested in 539871 stock information, you might also be interested in competitors like BSE:543220.

With a P/E ratio of 27.84, the stock appears relatively expensive compared to its index ^SBBMGLU at the moment.

The market capitalization of Thyrocare Technologies is currently at Rp57.32 B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 11.88.

With one share of Thyrocare Technologies investors achieved a dividend of Rp30.77. This results in a good dividend yield of 2.84%. In the last 2 years, the annual dividend has risen constantly.

For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.62. The price of the stock BSE:539871 is therefore subject to moderate fluctuations in relation to the overall market.

75.14% of 539871 Stocks is owned by insiders.

Since not enough Wall Street analysts have published their estimates, we are unfortunately unable to provide a reliable price target for the 539871 stock.

BSE:539871 has a 52 week range of Rp830.05 - Rp1,465.90 and is currently trading around Rp1,083.40.

The low short sale ratio indicated that the value might increase in the foreseeable future.

1
Underperform
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
35.4
Market Cap
57.32B
LT Debt/Cap
0.01%
Price-to-book Ratio
11.88
Earnings
08/12/2022
Dividend
Rp30.77
Div Yld
2.84%
Dividend Growth
2 Years
Beta
0.62
Short Interest
0.00%
Forecast 1Y
28.36%
Analyst Price Target
Rp0.00
LTG 5Y
27.84%
52 week range
Rp830.05 - Rp1,465.90
Country